|
|
The Anatomical Therapeutic Chemical (ATC) classification system
|
|
|
|
|
Level 5
L - Antineoplastic and immunomodulating agentsL01 - Antineoplastic agentsL01X - Other antineoplastic agentsL01XC - Monoclonal antibodiesL01XC12 - Brentuximab Vedotin
Brentuximab Vedotin
|
|
|